AtriCure (ATRC) Misses Q1 EPS by 4c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.44 --0%
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
JFIN, KEQU, LASE, More
EPS Growth %: +92.3%
Financial Fact:
Loss from operations: -6.29M
Today's EPS Names:
JFIN, KEQU, LASE, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $47 million versus the consensus estimate of $45.46 million.
GUIDANCE:
AtriCure sees FY2018 revenue of $190-196 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Primoris cuts 2026 outlook on renewables cost overruns, COO exits
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
